Anula Jayasuriya, MD, PhD, is a life science venture capitalist with ATP Capital LLC based in New York City, and previously a partner with Skyline Ventures in Palo Alto, and prior to that with the German –US venture capital firm TVM, in San Francisco. Anula received a BA from Harvard summa cum laude, received an MD and PhD (in Microbiology and Molecular Genetics) from Harvard Medical School, and completed an internship at Children’s Hospital in Boston before leaving for Harvard Business School where she received her MBA. Anula’s expertise consists of a unique combination of business, basic science and medical knowledge. She was VP- Corporate development at Genomics Collaborative Inc, a Genomics company in Cambridge where she was responsible for business development activities and forging alliances with biotech, institutional, academic and pharmaceutical collaborators. She was also a Vice President, Global Drug Development at Hoffman-La Roche for opportunistic infections in AIDS and Transplantation. Prior to that she was in the US sales and marketing arm of Syntex, a California pharmaceutical company that was acquired by Roche.
-
